InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,619.60
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.87
(
-0.73%
)
Bitcoin
62,335.63
(
-1.32%
)
Post# of 251748
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 828
Posts 119591
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 123561

Thursday, 07/28/2011 5:57:17 AM

Thursday, July 28, 2011 5:57:17 AM

Post# of 251748
NVS/MNTA had a 55% share of US Lovenox dollar sales in 2Q11. Here’s the arithmetic:

SNY’s 2Q11 US Lovenox sales were €160M (down from €222M in 1Q11): : http://en.sanofi.com/binaries/20110728_RESULTSQ2_en_tcm28-33120.pdf (page 4 and page 20). At the average exchange rate during 2Q11 of 1.43 dollars per euro, €160M translates into $229M.

Since NVS sold $284M of generic Lovenox in 2Q11 (#msg-65315981), 2Q11 total branded + generic US sales of Lovenox were $513M (up from $469M in 1Q11). 284/513 = 55%.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up